Читать книгу Protocols for High-Risk Pregnancies - Группа авторов - Страница 56
Suggested reading
Оглавление1 American College of Obstetricians and Gynecologists. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. Obstet Gynecol 2012; 120:1532–34.
2 American College of Obstetricians and Gynecologists. Practice Bulletin No. 162. Prenatal diagnostic testing for genetic disorders. Obstet Gynecol 2016; 127:e108–22.
3 Bianchi DW, Crombleholme TM, d’Alton ME, Malone FD. Fetology: Diagnosis and Management of the Fetal Patient, 2nd edn. New York: McGraw Hill, 2010.
4 Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis. Ultrasound Obstet Gynecol 2017; 50(3):302–14.
5 Kaimal AJ, Norton ME, Kuppermann M. Prenatal testing in the genomic age: clinical outcomes, quality of life, and costs. Obstet Gynecol 2015; 126(4):737–46.
6 Malone FD, Canick JA, Ball RH, et al. A comparison of first trimester screening, second trimester screening, and the combination of both for evaluation of risk for Down syndrome. N Engl J Med 2005; 353:2001–11.
7 Norton ME, Jacobsson B, Swamy GK, et al. Cell‐free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372(17):1589–97.
8 Nyberg DA, Souter VL. Chromosomal abnormalities. In: Nyberg DA, McGahan JP, Pretorius DH, Pilu G (eds) Diagnostic Imaging of Fetal Anomalies. Philadelphia: Lippincott Williams & Wilkins, 2003; pp. 861–906.
9 Palomaki GE, Kloza EM, Lambert‐Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13:913–20.
10 Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta‐analysis. Ultrasound Obstet Gynecol 2019; 54(4):442–51.
11 Society for Maternal‐Fetal Medicine (SMFM), Norton ME, Biggio JR, Kuller JA, Blackwell SC. SMFM Consult Series #42: The role of ultrasound in women who undergo cell‐free DNA screening. Am J Obstet Gynecol 2017; 216(3):B2–B7.